A White House official confirmed her role to Business Insider on Tuesday, though Gleason herself has yet to make a public statement. Tuesday evening, her X (formerly Twitter) account remained private. In her bio, she described herself as having previously worked on the “COVID response with US Digital Service.”
Connections to Russell Street Ventures
Gleason’s extensive experience in healthcare extends beyond the public sector. Between November 2021 and December 2024, she worked with Russell Street Ventures, a health industry investment firm founded by Brad Smith.
Smith, and Kendall Lindemann, were previously identified as DOGE employees by Business Insider. According to her LinkedIn, Gleason took on a senior advisory role in January 2025.
From 2014 to 2018, she served as the vice president of research for the Cure JM Foundation, a nonprofit organization dedicated to finding treatments for juvenile myositis, a rare autoimmune disease. She has been running her own consulting company in the Tampa/St. Petersburg, Florida, area since 2018.
Questions Remain
Despite the White House’s confirmation of Gleason’s role, there remains skepticism regarding her actual influence within DOGE.
